Therapy News and Research

RSS

Radical new technology could end drilling and filling misery at the dentist

Radical new dental technology could mean the end of the drilling and filling misery many endure at the dentists.

22 Jul 2008

Defining healthcare needs for chronic illness

A research paper in the latest issue of Medical Journal of Australia has provided the first insight into the prevalence and patterns of multimorbidity in Australia. About three in 10 people who saw a GP in 2005, and one in four Australians have multimorbidity (two or more types of chronic conditions).

22 Jul 2008

Suspect protein HMGB1 found to promote DNA repair, prevent cancer

An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA repair, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Proceedings of the National Academies of Science.

21 Jul 2008

Study shows promising results in deep brain stimulation for treatment-resistant depression

New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.

21 Jul 2008

First human tests of an injectable vaccine grown in genetically engineered plants

Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.

21 Jul 2008

CUPID cannabinoid MS study reaches milestone

The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.

21 Jul 2008

Gene expression test could help determine who needs more aggressive treatment

Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment.

21 Jul 2008

HALO Ablation System shows great promise for precancerous esophagus disease

BARRX Medical, Inc. has announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system.

21 Jul 2008

Access to rheumatoid arthritis drugs 'curbed' for sufferers in the UK

Sufferers of rheumatoid arthritis in Britain have been warned that their access to a particularly effective class of drug will in future be limited.

20 Jul 2008

Reduced dose anthracycline post-breast cancer surgery has no effect on outcome

Canadian researchers have discovered that there is a low risk of adverse effect from reducing post-op chemo by up to 25%, according to findings published in the online journal ecancermedicalscience.

20 Jul 2008

Stem cell chicken and egg debate moves to unlikely arena: the testes

Logic says it has to be the niche. As air and water preceded life, so the niche, that hospitable environment that shelters adult stem cells in many tissues and provides factors necessary to keep them young and vital, must have emerged before its stem cell dependents.

20 Jul 2008

Sleep patterns and ischemic risk in postmenopausal women

Postmenopausal women who regularly sleep more than nine hours a night may have an increased risk of ischemic stroke, researchers reported in Stroke: Journal of the American Heart Association.

19 Jul 2008

A search for the best prostate cancer treatment

A new Cancer Research UK clinical trial has been launched to investigate the best treatment options for men who have had surgery for early stage prostate cancer.

18 Jul 2008

Breast cancer researchers call for ethnicity to be taken into account when developing treatments

Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in today's Lancet by researchers from Imperial College London.

17 Jul 2008

Could arthritis wonder drugs provide clues for all disease?

Drugs that have helped treat millions of rheumatoid arthritis sufferers may hold the key to many more medical conditions, including atherosclerosis - a leading cause of heart disease - says the researcher who jointly invented and developed them.

From The University of Manchester 17 Jul 2008

You are not alone - help for breast cancer patients

Breast cancer is the most common female cancer in the UK, affecting one in nine women at some point in their life. The first patient-led DVD for women with breast cancer who are considering breast reconstruction will be launched today. It is hoped the DVD will change the way information is provided for women facing difficult surgical choices.

17 Jul 2008

New discovery on Candida infections

Scientists here have found that certain substances from bacteria living in the human intestine cause the normally harmless Candida albicans fungus to become highly infectious.

17 Jul 2008

Fred Hutchinson awarded $7.6 million to research how genetic variations influence risk of common diseases

Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four U.S. research institutes to receive grants totaling about $31 million toward this effort.

17 Jul 2008

The aorta is torn apart in Marfan syndrome

A severe complication of the Marfan syndrome is that the aorta may split and be torn apart. The patient can be protected if the syndrome is diagnosed and treated in good time.

17 Jul 2008

EpiCept and GNI partner to develop anti-viral hepatitis drug in Asia

GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI’s wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.

17 Jul 2008